Does OFATUMUMAB Cause Multiple sclerosis relapse? 1,525 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,525 reports of Multiple sclerosis relapse have been filed in association with OFATUMUMAB (ARZERRA). This represents 5.1% of all adverse event reports for OFATUMUMAB.
1,525
Reports of Multiple sclerosis relapse with OFATUMUMAB
5.1%
of all OFATUMUMAB reports
2
Deaths
361
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From OFATUMUMAB?
Of the 1,525 reports, 2 (0.1%) resulted in death, 361 (23.7%) required hospitalization, and 15 (1.0%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 1,525 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Covid-19 (1,435)
Asthenia (1,393)
Gait disturbance (1,342)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
INTERFERON BETA-1B (1,229)
PEGINTERFERON BETA-1A (945)
Which OFATUMUMAB Alternatives Have Lower Multiple sclerosis relapse Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB